Evidence map›Paper›PMID 39598150›Full record

ArticleLife (Basel, Switzerland)2024

Clinical Efficacy and Safety of Ultrasound-Guided Injection with Low-Molecular-Weight Peptides from Hydrolyzed Collagen in Patients with Partial Supraspinatus Tendon Tears: A Pilot Study.

Luca Latini, Francesco Porta, Vincenzo Maccarrone, Davide Zompa, Edoardo Cipolletta, Riccardo Mashadi Mirza, Emilio Filippucci, Florentin Ananu Vreju

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luca LatiniCentro Medico e Fisioterapia "Salute e Benessere"-Senigallia, 60019 Ancona, Italy.
Francesco PortaInterdisciplinary Pain Medicine Unit, Rheumatology Section, Santa Maria Maddalena Hospital, Occhiobello, 45030 Rovigo, Italy.
Vincenzo MaccarroneRheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
Davide ZompaRheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
Edoardo CipollettaRheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.ORCID 0000-0002-6881-8197
Riccardo Mashadi MirzaRadiology Unit, Riccione-Cattolica Hospital, 47923 Rimini, Italy.
Emilio FilippucciRheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
Florentin Ananu VrejuDepartment of Rheumatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study evaluates the clinical efficacy and safety of two ultrasound (US)-guided injections of a 5 mg/1 mL low-molecular-weight peptide (LWP) solution derived from hydrolyzed bovine collagen in patients with supraspinatus partial tendon tears.

methodsA total of 21 patients with symptomatic partial tears of the supraspinatus tendon, detected by US, were consecutively enrolled and received one injection at a baseline visit (T0) and one after two weeks (T1). The primary outcome measure was the visual analogue scale (VAS) for pain. Secondary outcomes were the shoulder pain and disability index (SPADI) total score and the safety of LWP injections. Patients were examined at baseline (T0), at a week 2 follow-up visit (T1), and at a week 12 follow-up visit (T2).

resultsA statistically significant improvement was found for both VAS pain and SPADI total scores, between T0 and T2 visits. US-guided injections were well tolerated and, apart from one patient with a progression of a tendon tear, no adverse events were recorded.

conclusionsIntratendinous tear US-guided injection therapy with an LWP solution was found to be safe and effective in improving both pain and shoulder function at a 12-week follow-up visit. The present pilot study should be considered the first step justifying a larger confirmatory investigation.

Indexed as

hydrolyzed collagen peptidesshoulder painsupraspinatus tendon tearultrasonographyUS-guided injections

Identifiers

PMID39598150
PMCPMC11595708

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.